Synonyms: AZD-8797 | AZD8797 | compound 18a [PMID: 23516963] | KAND-567 | KAND567
Compound class:
Synthetic organic
Comment: The chemical structure for rugocrixan was derived from WHO proposed INN list 132 (Feb 2025), in which it is listed as CX3C chemokine receptor 1 (CX3CR1) antagonist and anti-inflammatory agent. A structural match in PubChem provides the synonyms AZD8797 [1-2] and KAND567 which appear to be names for the same compound. Rugocrixan is a non-competitive allosteric modulator of CX3CR1, blocking activation of the receptor by the chemotactic cytokine CX3CL1 (fractalkine) [2]. As CX3CL1 is invloved in regulating the function of certain immune and cancer cells, this inhibitor has potential therapeutic applications in inflammatory conditions and cancer [3]. There is also evidence of a link between CX3CR1/CX3CL1 signalling and coronary artery disease [4].
COVID-19: Kancera initiated a clinical trial to evaluate the efficacy of rugocrixan (KAND567) to reduce SARS-CoV-2-associated lung inflammation, but the study was terminated due to slow recruitment of subjects. ![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Download 2D Structure ![]() |
|
Canonical SMILES | Download |
Isomeric SMILES | Download |
InChI standard identifier | Download |
InChI standard key | Download |
Molecular structure representations generated using Open Babel